NCT01842646 2021-06-14Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)H. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed35 enrolled 7 charts
NCT01546038 2020-03-03A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromePfizerPhase 2 Completed255 enrolled 82 charts 1 FDA